Looking to build lasting wealth through investments? Consider these two elite companies with promising long-term growth prospects.
First up is Eli Lilly (LLY), a healthcare giant that has developed a groundbreaking weight-loss drug called Zepbound. This treatment helps individuals struggling with obesity and related health conditions by curbing hunger and promoting weight loss. With the potential to tap into a $130 billion market by 2030, analysts predict Eli Lilly’s earnings per share to grow by an impressive 63% annually over the next five years.
Next, we have Tesla (TSLA), a leader in the electric vehicle (EV) industry with a strong foothold in artificial intelligence (AI) and robotics. With the EV market expected to surpass $950 billion by 2030, Tesla’s innovative self-driving technology and plans for a fleet of autonomous vehicles could drive significant revenue growth. Additionally, the company’s development of AI-powered robots, like the humanoid robot Optimus, presents a massive profit opportunity estimated at $1 trillion.
Both Eli Lilly and Tesla offer compelling growth opportunities for investors looking to build wealth over the long term.